The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

Press release from Marketwire

BioExx Annual Meeting Presentation Available via Webcast

Monday, June 18, 2012

BioExx Annual Meeting Presentation Available via Webcast07:30 EDT Monday, June 18, 2012TORONTO, ONTARIO--(Marketwire - June 18, 2012) - BioExx Specialty Proteins Ltd. (TSX:BXI), the first company to commercialize a new and complete food-grade protein from a major global crop in 50 years, announced today that it will provide its management presentation to shareholders at its Annual General and Special Meeting on Thursday, June 21, 2012 at approximately 2:00 p.m. ET via a live audio webcast. The webcast will be available at www.bioexx.com, and will be archived on the Company's website for 60 days following the meeting date. About BioExx Specialty Proteins Ltd .Headquartered in Toronto, Canada, BioExx is focused on the separation of oil and high-value proteins from oilseeds for global food, beverage, nutrition, and other markets. BioExx employs trade secret, patented and patent-pending technologies that utilize significantly lower temperatures than conventional oilseed processing, in order to enable the improved separation of proteins from oilseeds. BioExx believes that these processes cumulatively have the potential to make a valuable contribution to global food and protein supply while maintaining an environmentally sustainable footprint.To find out more about BioExx Specialty Proteins Ltd. (TSX:BXI), please visit www.bioexx.com.The statements made in this press release include forward-looking statements that involve a number of risks and uncertainties. These statements relate to future events or future performance and reflect management's current expectations and assumptions. A number of factors could cause actual events, performance or results to differ materially from the events, performance and results discussed in the forward-looking statements, such as the economy, generally, competition in its target markets, the demand for BioExx's products, the availability of funding, the efficacy of its technology, and the anticipated costs of BioExx's plant construction and operation. These forward-looking statements are made as of the date hereof and BioExx does not assume any obligation to update or revise them to reflect new events or circumstances. Actual events or results could differ materially from BioExx's expectations and projections.FOR FURTHER INFORMATION PLEASE CONTACT: Chris SchnarrBioExx Specialty Proteins Ltd.Chief Executive Officer(416) 588-4442 x111cschnarr@bioexx.comwww.bioexx.comORScott KoyichInvestor Relations: Brisco Capital PartnersPresident(403) 262-9888scott@briscocapital.com